
A Brand New Class of Antidepressants Is Being Reviewed by The FDA, And It’s a ‘Game-Changer’ For Postpartum
A Brand New Class of Antidepressants Is Being Reviewed by The FDA, And It’s a ‘Game-Changer’ For Postpartum https://ift.tt/2NcP7ME A promising new treatment for postpartum depression (PPD) could mark a major step forward in women’s health care, researchers say. Brexanolone injection works differently than existing antidepressant medications, and if approved by the US Food and Drug Administration later this year, will be the first new class of antidepressants in decades, and the first drug specifically indicated for PPD. "With current antidepressant SSRIs (selective serotonin reuptake inhibitors) it could take four to six weeks to get a treatment response. In […]